16
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Long noncoding RNA LINC00662 promotes M2 macrophage polarization and hepatocellular carcinoma progression via activating Wnt/β‐catenin signaling

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Tumor‐associated macrophages have important roles in hepatocellular carcinoma (HCC) initiation and progression. Long noncoding RNAs (lncRNAs) have also been reported to be involved in HCC. In this study, we explored how lncRNA LINC00662 may influence HCC progression through both tumor cell‐dependent and macrophage‐dependent mechanisms. LINC00662 was found to be upregulated in HCC, and high LINC00662 levels correlated with poor survival of HCC patients. LINC00662 upregulated WNT3A expression and secretion via competitively binding miR‐15a, miR‐16, and miR‐107. Through inducing WNT3A secretion, LINC00662 activated Wnt/β‐catenin signaling in HCC cells in an autocrine manner and further promoted HCC cell proliferation, cell cycle, and tumor cell invasion, while repressing HCC cell apoptosis. In addition, acting through WNT3A secretion, LINC00662 activated Wnt/β‐catenin signaling in macrophages in a paracrine manner and further promoted M2 macrophage polarization. Via activating Wnt/β‐catenin signaling and M2 macrophages polarization, LINC00662 significantly promoted HCC tumor growth and metastasis in vivo. Hence, targeting LINC00662 may provide novel therapeutic strategy against HCC.

          Abstract

          Schematic model of LINC00662 functions. LINC00662 upregulates WNT3A expression and secretion via competitively binding miR‐15a/16/107. Secreted WNT3A activates Wnt/β‐catenin in HCC cells in an autocrine manner and promotes HCC cell proliferation and invasion. Secreted WNT3A also activates Wnt/β‐catenin in macrophages in a paracrine manner and promotes M2 macrophage polarization. Finally, LINC00662 promotes HCC tumor growth and metastasis via upregulating WNT3A.

          Related collections

          Most cited references39

          • Record: found
          • Abstract: found
          • Article: not found

          Prediction of venous metastases, recurrence, and prognosis in hepatocellular carcinoma based on a unique immune response signature of the liver microenvironment.

          Hepatocellular carcinoma (HCC) is an aggressive malignancy mainly due to metastases or postsurgical recurrence. We postulate that metastases are influenced by the liver microenvironment. Here, we show that a unique inflammation/immune response-related signature is associated with noncancerous hepatic tissues from metastatic HCC patients. This signature is principally different from that of the tumor. A global Th1/Th2-like cytokine shift in the venous metastasis-associated liver microenvironment coincides with elevated expression of macrophage colony-stimulating factor (CSF1). Moreover, a refined 17 gene signature was validated as a superior predictor of HCC venous metastases in an independent cohort, when compared to other clinical prognostic parameters. We suggest that a predominant humoral cytokine profile occurs in the metastatic liver milieu and that a shift toward anti-inflammatory/immune-suppressive responses may promote HCC metastases.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Extracellular vesicle-packaged HIF-1α-stabilizing lncRNA from tumour-associated macrophages regulates aerobic glycolysis of breast cancer cells

            Metabolic reprogramming is a hallmark of cancer. Here, we demonstrate that tumour-associated macrophages (TAMs) enhance the aerobic glycolysis and apoptotic resistance of breast cancer cells via the extracellular vesicle (EV) transmission of a myeloid-specific lncRNA, HIF-1α-stabilizing long noncoding RNA (HISLA). Mechanistically, HISLA blocks the interaction of PHD2 and HIF-1α to inhibit the hydroxylation and degradation of HIF-1α. Reciprocally, lactate released from glycolytic tumour cells upregulates HISLA in macrophages, constituting a feed-forward loop between TAMs and tumour cells. Blocking EV-transmitted HISLA inhibits the glycolysis and chemoresistance of breast cancer in vivo. Clinically, HISLA expression in TAMs is associated with glycolysis, poor chemotherapeutic response and shorter survival of patients with breast cancer. Our study highlights the potential of lncRNAs as signal transducers that are transmitted between immune and tumour cells via EVs to promote cancer aerobic glycolysis.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              KRAS-IRF2 Axis Drives Immune Suppression and Immune Therapy Resistance in Colorectal Cancer

              The biological functions and mechanisms of oncogenic KRAS G12D (KRAS*) in resistance to immune checkpoint blockade (ICB) therapy are not fully understood. We demonstrate that KRAS* represses the expression of interferon regulatory factor 2 (IRF2), which in turn directly represses CXCL3 expression. KRAS*-mediated repression of IRF2 results in high expression of CXCL3, which binds to CXCR2 on myeloid-derived suppressor cells (MDSCs) and promotes their migration to the tumor microenvironment. Anti-PD-1 resistance of KRAS*-expressing tumors can be overcome by enforced IRF2 expression or by the inhibition of CXCR2. Colorectal cancer (CRC) showing higher IRF2 expression exhibited increased responsiveness to anti-PD-1 therapy. The KRAS*-IRF2-CXCL3-CXCR2 axis provides a framework for patient selection and combination therapies to enhance the effectiveness of ICB therapy in CRC.
                Bookmark

                Author and article information

                Contributors
                dk99_bao@sina.cn
                Journal
                Mol Oncol
                Mol Oncol
                10.1002/(ISSN)1878-0261
                MOL2
                Molecular Oncology
                John Wiley and Sons Inc. (Hoboken )
                1574-7891
                1878-0261
                21 December 2019
                February 2020
                : 14
                : 2 ( doiID: 10.1002/mol2.v14.2 )
                : 462-483
                Affiliations
                [ 1 ] Department of Clinical Laboratory Henan Provincial People's Hospital Henan University People’s Hospital Zhengzhou China
                [ 2 ] Laboratory of Cancer Biomarkers and Liquid Biopsy School of Pharmacy Henan University Kaifeng China
                [ 3 ] Microbiome Laboratory Henan Provincial People's Hospital Henan University People’s Hospital Zhengzhou China
                [ 4 ] Department of Hepatobiliary Pancreatic Surgery Henan Provincial People's Hospital Henan University People’s Hospital Zhengzhou China
                Author notes
                [*] [* ] Correspondence

                D. Bao, School of Pharmacy, Laboratory of Cancer Biomarkers and Liquid Biopsy, Henan University, Kaifeng 475004, China

                Fax: +86 371 23880602

                Tel: +86 371 23880602

                E‐mail: dk99_bao@ 123456sina.cn

                Author information
                https://orcid.org/0000-0002-6503-934X
                Article
                MOL212606
                10.1002/1878-0261.12606
                6998656
                31785055
                8b882962-c422-4c2f-9833-d635485961ad
                © 2019 The Authors. Published by FEBS Press and John Wiley & Sons Ltd.

                This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.

                History
                : 06 September 2019
                : 29 October 2019
                : 27 November 2019
                Page count
                Figures: 8, Tables: 1, Pages: 22, Words: 11404
                Funding
                Funded by: National Natural Science Foundation of China , open-funder-registry 10.13039/501100001809;
                Award ID: 31502041
                Award ID: 81702049
                Funded by: Key Science and Technology Fund of Henan Province in China
                Award ID: 182102310120
                Categories
                Research Article
                Research Articles
                Custom metadata
                2.0
                February 2020
                Converter:WILEY_ML3GV2_TO_JATSPMC version:5.7.5 mode:remove_FC converted:04.02.2020

                Oncology & Radiotherapy
                cerna,hepatocellular carcinoma,linc00662,long noncoding rna,macrophage polarization,wnt/β‐catenin signaling

                Comments

                Comment on this article